ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryFinance & InsuranceHolding CompaniesBaselBeOne Medicines AG
BeOne Medicines AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

BeOne Medicines AG develops cancer medicines and conducts research and clinical development in oncology, focusing on targeted therapies for hematologic malignancies and solid tumors. The company advances a pipeline of investigational therapies, runs global clinical trials and collaborates on development, manufacturing and patient access.

AI-generated
Offering

Products & services

Industry:Holding Companies
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

BeOne Medicines AG

✓ Offered
9
Cancer medicines
Cancer medicines, including BRUKINSA (zanubrutinib), TEVIMBRA (tislelizumab-jsgr) and BEQALZI (sonrotoclax).
Clinical trials
Clinical trials in haematology, lung cancer, stomach cancer, breast cancer and other indications; opportunities to participate and obtain information for patients and healthcare professionals.
Research and development
Research and development for oncology therapies with a focus on haematology and solid tumours, as well as approaches such as CDACs and antibody drug conjugates.
Patient Support Program
Personalised support for prescribed patients, including insurance and co-pay assistance, education and help with financial, advisory and transportation needs.
Expanded Access Program
Access to investigational products for patients with no other treatment options and not participating in a clinical trial, in compliance with local regulations.
Partnerships for development, manufacturing and access
Partnerships with biotech, pharma and academic partners for process design, manufacturing, regulatory strategy, global clinical trials and market access.
Manufacturing of medicines
Manufacturing of small molecules, biologics, antibody drug conjugates, oral dosage forms and injectables, as well as analytical and process development.
Treatment of haematological malignancies
Treatment of B-cell disorders and other haematological malignancies with agents such as Zanubrutinib, Sonrotoclax and Blinatumomab in the pipeline or approved.
Treatment of solid tumours
Treatment of solid tumours, including lung, gastrointestinal, breast and gynaecological cancers, with approved and development-stage agents.
Trust & reputation

ranQ Trust Score of BeOne Medicines AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 54% · As of October 2026

BeOne Medicines AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
BeOne Medicines AG scores 60.1 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.25.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
BeOne Medicines AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
BeOne Medicines AG scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

BeOne Medicines AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once BeOne Medicines AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

BeOne Medicines AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BeOne Medicines AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BeOne Medicines AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aeschengraben 27
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-446.472.541
Founded
2025 · 1 year
Last commercial register change
August 6, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    IG
    INTERPANE GLASS HOLDING AG
    Basel
    FS
    Fruselva Suisse AG
    Basel
    SR
    Swiss Rockets AG
    Basel
    SH
    Straumann Holding AG
    Basel
    KI
    Kuboid Invest AG
    Basel
    AA
    Adesse AG
    Riehen
    AC
    Applied Chemicals International Group AG
    Basel
    HA
    HANAKU AG
    Basel